ArticleBreast cancer research : BCR2021

Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy.

Li Cong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.